DROPERIDOL (Inapsine)

ACTION: Butyrophenone

•  Droperidol produces a dopaminergic blockage, a mild alpha-adrenergic blockage,

and causes peripheral vasodilation

•  Onset of Action: 3 to 10 minutes after IM administration
•  Duration: 2-3 hours

INDICATIONS: First line medication for severely agitated patients who pose serious
probable and imminent bodily harm to self/others

CONTRAINDICATIONS:

•  Suspected acute myocardial infarction/acute coronary syndrome
•  Hypotension
•  Pregnancy
•  Dementia related psychosis
•  Patients < 18 years

POTENTIAL SIDE EFFECTS

•  Transient hypotension
•  Dystonic reaction
•  Extra-pyramidal reactions
•  Sedation

ADULT DOSE:

5mg Intramuscular X 1

PEDIATRIC DOSE:

N/A

NOTES:

•  Caution use in patients >60 years of age
•  May cause prolonged QT interval. Caution in patients with known prolonged QT

syndrome or recent simultaneous use of other QT-prolonging drugs.

•  All patients receiving droperidol should be placed on cardiac monitoring and EtCO2

monitoring.

•  Avoid patients known to be pregnant, regardless of gestational age
•  Contact Base Hospital if additional doses of droperidol or midazolam are needed for

patients with continued agitation after first dose of droperidol.

Effective: 10/1/25
Supersedes: NEW

